Previous close | 0.7500 |
Open | 1.0000 |
Bid | 0.9500 |
Ask | 1.1000 |
Strike | 30.00 |
Expiry date | 2025-01-17 |
Day's range | 1.0000 - 1.0200 |
Contract range | N/A |
Volume | |
Open interest | 562 |
Baxter (BAX) reports better-than-expected first-quarter earnings and sales. BAX's quarterly results reflect solid demand for a range of its medically essential products.
Robust Operational Performance Drives Growth Amidst Strategic Transformations
Baxter (BAX) delivered earnings and revenue surprises of 6.56% and 1.20%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?